Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.05M Sell
18,044
-64,910
-78% -$3.77M 0.05% 400
2017
Q1
$4.85M Buy
+82,954
New +$4.7M 0.24% 121
2015
Q4
Sell
-88,013
Closed -$5.16M 815
2015
Q3
$5.16M Buy
88,013
+8,063
+10% +$532K 0.31% 100
2015
Q2
$5.14M Buy
+79,950
New +$4.89M 0.29% 103
2014
Q4
Sell
-51,751
Closed -$2.22M 690
2014
Q3
$2.22M Buy
+51,751
New +$2.32M 0.15% 189
2013
Q4
Sell
-22,135
Closed -$744K 561
2013
Q3
$744K Buy
+22,135
New +$720K 0.14% 180

Other funds holding ALKS

Airain Ltd's ALKS Position: Q2 2017 in Review

Airain Ltd reduced its Alkermes (ALKS) stake by 78% in Q2 2017, selling an estimated $3.77M and leaving 18,044 shares worth $1.05M. The position accounts for 0.05% of the portfolio, ranked #400.

Airain Ltd first reported a position in ALKS in Q3 2013 and has held it in 6 quarters since. The position peaked at $5.16M in Q3 2015. 256 funds tracked by Wall St. Rank hold ALKS as of Q2 2017.

  • Airain Ltd held 18,044 shares of Alkermes worth $1.05M as of Q2 2017.
  • Airain Ltd sold 64,910 Alkermes shares in Q2 2017, an estimated $3.77M.
  • Alkermes made up 0.05% of Airain Ltd's portfolio in Q2 2017, its #400 holding.
  • Airain Ltd first reported a position in Alkermes in Q3 2013 and has held it in 6 quarters since.
  • Airain Ltd's Alkermes position peaked at $5.16M in Q3 2015.
  • 256 funds tracked by Wall St. Rank held Alkermes as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.